Elanix Biotechnologies AG
F:ELN

Watchlist Manager
Elanix Biotechnologies AG Logo
Elanix Biotechnologies AG
F:ELN
Watchlist
Price: 0.053 EUR -11.67% Market Closed
Market Cap: €428.3k

Wall St Price Targets

ELN Price Targets Summary
Elanix Biotechnologies AG

There are no price targets for ELN.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Elanix Biotechnologies AG Competitors:
Price Targets
ENR
Energizer Holdings Inc
-4% Downside
BALY
Bally's Corp
-8% Downside
3491
Universal Microwave Technology Inc
41% Upside

Revenue
Forecast

N/A
Past Growth
513% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
513% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Revenue over the next 1 year is 513%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Elanix Biotechnologies AG

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Elanix Biotechnologies AG

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for Elanix Biotechnologies AG
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ELN's stock price target?
Not Available

ELN does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Elanix Biotechnologies AG?
Projected CAGR
513%

The compound annual growth rate for Revenue over the next 1 year is 513%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett